Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells

This publication has 27 references indexed in Scilit:

• MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats
  Carcinogenesis: Integrative Cancer Research, 1996
• Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
  Science, 1995
• The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells
  Leukemia Research, 1994
• Inhibition of Topoisomerase IIα Activity in CHO K1 Cells by 2-[(Aminopropyl)Amino]Ethanethiol (WR-1065)
  Radiation Research, 1994
• Soy intake and cancer risk: A review of thein vitroandin vivodata
  Nutrition and Cancer, 1994
• Genistein, a Tyrosine Kinase Inhibitor, Blocks the Cell Cycle Progression but not Ca2+ Influx Induced by BAY K8644 in FRTL-5 Cells
  Biochemical and Biophysical Research Communications, 1993
• [30] Use and specificity of genistein as inhibitor of protein-tyrosine kinases
  Published by Elsevier ,1991
• Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cells
  Biochemical and Biophysical Research Communications, 1988
• Phytoestrogen Interaction with Estrogen Receptors in Human Breast Cancer Cells*
  Endocrinology, 1978
• Estrogenic Activity of Isoflavone Derivatives Extracted and Prepared from Soybean Oil Meal
  Science, 1953